Massachusetts Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $899K | Sell |
3,726
-536
| -13% | -$129K | ﹤0.01% | 821 |
|
|
2025
Q1 | $1.04M | Buy |
4,262
+665
| +18% | +$162K | ﹤0.01% | 807 |
|
|
2024
Q4 | $1.18M | Sell |
3,597
-50,566
| -93% | -$16.6M | ﹤0.01% | 803 |
|
|
2024
Q3 | $18.1M | Sell |
54,163
-294,377
| -84% | -$98.5M | 0.01% | 603 |
|
|
2024
Q2 | $95.2M | Buy |
348,540
+1,288
| +0.4% | +$352K | 0.03% | 380 |
|
|
2024
Q1 | $120M | Buy |
347,252
+24,958
| +8% | +$8.63M | 0.04% | 352 |
|
|
2023
Q4 | $104M | Sell |
322,294
-1,423
| -0.4% | -$459K | 0.03% | 372 |
|
|
2023
Q3 | $116M | Buy |
+323,717
| New | +$116M | 0.04% | 339 |
|